• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚马来亚大学医学中心 pks+ 大肠杆菌与结直肠癌的流行率及其相关性。

Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia.

机构信息

Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

University of Malaya Centre of Proteomics Research (UMCPR), University of Malaya, Kuala Lumpur, Malaysia.

出版信息

PLoS One. 2020 Jan 28;15(1):e0228217. doi: 10.1371/journal.pone.0228217. eCollection 2020.

DOI:10.1371/journal.pone.0228217
PMID:31990962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6986756/
Abstract

Escherichia coli (E. coli) from the B2 phylogenetic group is implicated in colorectal cancer (CRC) as it possesses a genomic island, termed polyketide synthetase (pks), which codes for the synthesis of colibactin, a genotoxin that induces DNA damage, cell cycle arrest, mutations and chromosomal instability in eukaryotic cells. The aim of this study was to detect and compare the prevalence of E. coli expressing pks (pks+ E. coli) in CRC patients and healthy controls followed by investigating the virulence triggered by pks+ E. coli using an in-vitro model. Mucosal colon tissues were collected and processed to determine the presence of pks+ E. coli. Thereafter, primary colon epithelial (PCE) and colorectal carcinoma (HCT116) cell lines were used to detect cytopathic response to the isolated pks+ E. coli strains. Our results showed 16.7% and 4.3% of CRC and healthy controls, respectively were pks+ E. coli. Further, PCE displayed syncytia and cell swelling and HCT116 cells, megalocytosis, in response to treatment with the isolated pks+ E. coli strains. In conclusion, pks+ E. coli was more often isolated from tissue of CRC patients compared to healthy individuals, and our in-vitro assays suggest these isolated strains may be involved in the initiation and development of CRC.

摘要

大肠杆菌(E. coli)属于 B2 进化群,与结直肠癌(CRC)有关,因为它具有一个基因组岛,称为聚酮合酶(pks),可编码产生 colibactin,这是一种遗传毒素,可在真核细胞中诱导 DNA 损伤、细胞周期停滞、突变和染色体不稳定性。本研究旨在检测和比较 CRC 患者和健康对照者中表达 pks 的大肠杆菌(pks+ E. coli)的流行率,然后使用体外模型研究 pks+ E. coli 引发的毒力。收集并处理粘膜结肠组织以确定 pks+ E. coli 的存在。然后,使用原代结肠上皮(PCE)和结直肠癌细胞(HCT116)细胞系检测分离的 pks+ E. coli 菌株对细胞的细胞病变效应。我们的结果显示,CRC 患者和健康对照者中 pks+ E. coli 的比例分别为 16.7%和 4.3%。此外,PCE 对分离的 pks+ E. coli 菌株的反应表现为合胞体和细胞肿胀,而 HCT116 细胞则表现为巨细胞症。总之,与健康个体相比,pks+ E. coli 更常从 CRC 患者的组织中分离出来,我们的体外试验表明这些分离株可能参与 CRC 的发生和发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2d/6986756/064298048ab9/pone.0228217.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2d/6986756/2ec36f9a2a24/pone.0228217.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2d/6986756/347d13a080ae/pone.0228217.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2d/6986756/b03e0b010585/pone.0228217.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2d/6986756/064298048ab9/pone.0228217.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2d/6986756/2ec36f9a2a24/pone.0228217.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2d/6986756/347d13a080ae/pone.0228217.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2d/6986756/b03e0b010585/pone.0228217.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2d/6986756/064298048ab9/pone.0228217.g004.jpg

相似文献

1
Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia.马来西亚马来亚大学医学中心 pks+ 大肠杆菌与结直肠癌的流行率及其相关性。
PLoS One. 2020 Jan 28;15(1):e0228217. doi: 10.1371/journal.pone.0228217. eCollection 2020.
2
Association of Escherichia coli containing polyketide synthase in the gut microbiota with colorectal neoplasia in Japan.肠道微生物群中含聚酮合酶的大肠杆菌与日本结直肠癌的关系。
Cancer Sci. 2022 Jan;113(1):277-286. doi: 10.1111/cas.15196. Epub 2021 Nov 22.
3
Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani population.与结直肠癌相关的具有 colibactin 的大肠杆菌分离株及其在巴基斯坦人群中的遗传多样性。
PLoS One. 2022 Nov 11;17(11):e0262662. doi: 10.1371/journal.pone.0262662. eCollection 2022.
4
Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening setting.粪便中多酮合酶阳性大肠埃希菌一次性检测在筛查环境中对结直肠癌风险无提示作用。
J Pathol. 2024 Jun;263(2):217-225. doi: 10.1002/path.6276. Epub 2024 Mar 29.
5
Putrescine Supplementation Limits the Expansion of pks+ Escherichia coli and Tumor Development in the Colon.腐胺补充限制了 pks+ 大肠杆菌在结肠中的扩张和肿瘤发展。
Cancer Res Commun. 2024 Jul 1;4(7):1777-1792. doi: 10.1158/2767-9764.CRC-23-0355.
6
[Expression of enterotoxigenic Bacteroides fragilis and polyketide synthase gene-expressing Escherichia coli in colorectal adenoma patients].[产肠毒素脆弱拟杆菌和表达聚酮合酶基因的大肠杆菌在结直肠腺瘤患者中的表达]
Zhonghua Yi Xue Za Zhi. 2016 Mar 29;96(12):954-9. doi: 10.3760/cma.j.issn.0376-2491.2016.12.010.
7
Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients.结直肠癌患者肿瘤组织及周围正常黏膜组织中 Pks 阳性大肠埃希菌。
Cancer Sci. 2024 Apr;115(4):1184-1195. doi: 10.1111/cas.16088. Epub 2024 Jan 31.
8
Targeted depletion of + bacteria from a fecal microbiota using specific antibodies.利用特异性抗体靶向耗竭粪便微生物群中的+菌。
mSystems. 2023 Jun 29;8(3):e0007923. doi: 10.1128/msystems.00079-23. Epub 2023 May 23.
9
Genetic diversity, phylogroup distribution and virulence gene profile of pks positive Escherichia coli colonizing human intestinal polyps.定植于人类肠道息肉的产志贺毒素大肠埃希氏菌的遗传多样性、系统发育群分布和毒力基因特征。
Microb Pathog. 2017 Nov;112:274-278. doi: 10.1016/j.micpath.2017.10.009. Epub 2017 Oct 5.
10
Selective pks+ Escherichia coli strains induce cell cycle arrest and apoptosis in colon cancer cell line.选择性多药耐药基因阳性+大肠杆菌菌株诱导结肠癌细胞系细胞周期停滞和凋亡。
World J Microbiol Biotechnol. 2023 Oct 6;39(12):333. doi: 10.1007/s11274-023-03767-1.

引用本文的文献

1
It Is Time to Consider the Lost Battle of Microdamaged Piezo2 in the Context of and Early-Onset Colorectal Cancer.是时候在早期结直肠癌的背景下考虑微损伤Piezo2的败北了。
Int J Mol Sci. 2025 Jul 24;26(15):7160. doi: 10.3390/ijms26157160.
2
A possible role of urinary genotoxic Escherichia coli in prostate cancer in Nigerian patients.尿源性基因毒性大肠杆菌在尼日利亚前列腺癌患者中的潜在作用。
BMC Res Notes. 2025 Jul 14;18(1):289. doi: 10.1186/s13104-025-07369-y.
3
Anticancer Effects of -Derived Outer Membrane Vesicles against Colorectal Cancer Cells through Regulation of Apoptosis.

本文引用的文献

1
Adenomas - Genetic factors in colorectal cancer prevention.腺瘤——结直肠癌预防中的遗传因素。
Rep Pract Oncol Radiother. 2018 Mar-Apr;23(2):75-83. doi: 10.1016/j.rpor.2017.12.003. Epub 2018 Feb 9.
2
Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.基于生活方式、环境和遗传因素确定结直肠癌风险和筛查起始年龄。
Gastroenterology. 2018 Jun;154(8):2152-2164.e19. doi: 10.1053/j.gastro.2018.02.021. Epub 2018 Feb 17.
3
The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy.
源自[具体来源未提及]的外膜囊泡通过调控细胞凋亡对结肠癌细胞的抗癌作用
Iran J Public Health. 2025 Jun;54(6):1310-1319. doi: 10.18502/ijph.v54i6.18909.
4
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies.左右侧结直肠癌的多维差异及其对靶向治疗的影响。
NPJ Precis Oncol. 2025 Apr 22;9(1):116. doi: 10.1038/s41698-025-00892-y.
5
Intratumoural pksEscherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndrome.肿瘤内携带聚酮合酶基因的大肠杆菌与林奇综合征患者异时性结直肠癌及腺瘤发生风险相关。
EBioMedicine. 2025 Apr;114:105661. doi: 10.1016/j.ebiom.2025.105661. Epub 2025 Mar 29.
6
The synthesis of the novel toxin-colibactin and its mechanisms of tumorigenesis of colorectal cancer.新型毒素大肠杆菌素的合成及其在结直肠癌肿瘤发生中的机制。
Front Microbiol. 2024 Dec 18;15:1501973. doi: 10.3389/fmicb.2024.1501973. eCollection 2024.
7
Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery.结直肠癌患者与健康个体的微生物组差异:对疫苗抗原发现的启示
Immunotargets Ther. 2024 Dec 13;13:749-774. doi: 10.2147/ITT.S486731. eCollection 2024.
8
Colibactin-induced damage in bacteria is cell contact independent.大肠杆菌素诱导的细菌损伤与细胞接触无关。
mBio. 2025 Jan 8;16(1):e0187524. doi: 10.1128/mbio.01875-24. Epub 2024 Nov 22.
9
Escherichia coli on colorectal cancer: A two-edged sword.大肠杆菌与结直肠癌:一把双刃剑。
Microb Biotechnol. 2024 Oct;17(10):e70029. doi: 10.1111/1751-7915.70029.
10
Insights into the Two Most Common Cancers of Primitive Gut-Derived Structures and Their Microbial Connections.浅析两种最常见的原始肠源性结构癌症及其与微生物的关联。
Medicina (Kaunas). 2024 Sep 18;60(9):1515. doi: 10.3390/medicina60091515.
细胞衰老在肿瘤发生发展及其对癌症治疗反应中的双重作用
Front Oncol. 2017 Nov 23;7:278. doi: 10.3389/fonc.2017.00278. eCollection 2017.
4
Colorectal cancer-global burden, trends, and geographical variations.结直肠癌——全球负担、趋势及地理差异
J Surg Oncol. 2017 Apr;115(5):619-630. doi: 10.1002/jso.24578. Epub 2017 Feb 13.
5
[Expression of enterotoxigenic Bacteroides fragilis and polyketide synthase gene-expressing Escherichia coli in colorectal adenoma patients].[产肠毒素脆弱拟杆菌和表达聚酮合酶基因的大肠杆菌在结直肠腺瘤患者中的表达]
Zhonghua Yi Xue Za Zhi. 2016 Mar 29;96(12):954-9. doi: 10.3760/cma.j.issn.0376-2491.2016.12.010.
6
Incidence and mortality rates of colorectal cancer in Malaysia.马来西亚结直肠癌的发病率和死亡率
Epidemiol Health. 2016 Mar 9;38:e2016007. doi: 10.4178/epih.e2016007. eCollection 2016.
7
The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment.细菌遗传毒素 colibactin 通过改变肿瘤微环境促进结肠肿瘤生长。
Gut Microbes. 2014;5(5):675-80. doi: 10.4161/19490976.2014.969989.
8
Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer.微生物基因组分析揭示炎症在细菌诱导的结直肠癌中的关键作用。
Nat Commun. 2014 Sep 3;5:4724. doi: 10.1038/ncomms5724.
9
Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation.结肠癌相关的B2大肠杆菌定殖于肠道黏膜并促进细胞增殖。
World J Gastroenterol. 2014 Jun 7;20(21):6560-72. doi: 10.3748/wjg.v20.i21.6560.
10
Colonization of the human gut by E. coli and colorectal cancer risk.人类肠道中大肠杆菌的定植与结直肠癌风险。
Clin Cancer Res. 2014 Feb 15;20(4):859-67. doi: 10.1158/1078-0432.CCR-13-1343. Epub 2013 Dec 13.